Latest News about REspiratory syncytial virus
Recent news which mentions REspiratory syncytial virus
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
From CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
From CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023
From CNBC.com News
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
From CNBC.com News
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
From CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
December 26, 2022
Tickers
LIFE
From CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
November 01, 2022
From CNBC.com News
From Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
March 24, 2022
Tickers
PFE
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
October 04, 2021
Tickers
JNJ
From Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
September 02, 2021
Tickers
PFE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.